NEW YORK ( TheStreet) -- Medivation (Nasdaq: MDVN) hit a new 52-week high Wednesday as it is currently trading at $97.64, above its previous 52-week high of $97.09 with 18,572 shares traded as of 9:40 a.m. ET. Average volume has been 741,800 shares over the past 30 days. Medivation has a market cap of $3.46 billion and is part of the health care sector and drugs industry. Shares are up 108.3% year to date as of the close of trading on Tuesday. Medivation, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for the treatment of serious diseases in the United States and Europe.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!